Pancreatic cancer and melanoma related perceptions and behaviors following disclosure of CDKN2A variant status as a research result

This study examined whether participants who learned research results related to a germline CDKN2A variant known to be associated with increased risk of pancreatic cancer and malignant melanoma would pursue confirmatory testing and cancer screening, share the genetic information with health care providers and family, and change risk perceptions